These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 37888127)

  • 21. Use of guideline-recommended management in established coronary heart disease in the observational DYSIS II study.
    Ferrières J; Lautsch D; Ambegaonkar BM; De Ferrari GM; Vyas A; Baxter CA; Bash LD; Velkovski-Rouyer M; Horack M; Almahmeed W; Chiang FT; Poh KK; Elisaf M; Brudi P; Gitt AK
    Int J Cardiol; 2018 Nov; 270():21-27. PubMed ID: 29934227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
    Lee HY; Cooke CE; Robertson TA
    J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disparities in Secondary Prevention of Atherosclerotic Heart Disease After Coronary Artery Bypass Grafting in Northern Plains American Indians.
    Kruger H; Zumwalt C; Guenther R; Jansen R; Warne D; Dyke C
    Health Equity; 2019; 3(1):520-526. PubMed ID: 31656939
    [No Abstract]   [Full Text] [Related]  

  • 24. Medication adherence, biological and lifestyle risk factors in patients with myocardial infarction: a ten-year follow-up on socially differentiated cardiac rehabilitation.
    Hald K; Larsen FB; Nielsen KM; Meillier LK; Johansen MB; Larsen ML; Christensen B; Nielsen CV
    Scand J Prim Health Care; 2019 Jun; 37(2):182-190. PubMed ID: 31122102
    [No Abstract]   [Full Text] [Related]  

  • 25. Exercise-based cardiac rehabilitation for coronary heart disease.
    Anderson L; Thompson DR; Oldridge N; Zwisler AD; Rees K; Martin N; Taylor RS
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD001800. PubMed ID: 26730878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of patients with ST-segment elevation or non-ST-segment elevation acute coronary syndromes in cardiac rehabilitation centers.
    Reibis R; Völler H; Gitt A; Jannowitz C; Halle M; Pittrow D; Hildemann S
    Clin Cardiol; 2014 Apr; 37(4):213-21. PubMed ID: 24847509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Community health worker-based intervention for adherence to drugs and lifestyle change after acute coronary syndrome: a multicentre, open, randomised controlled trial.
    Xavier D; Gupta R; Kamath D; Sigamani A; Devereaux PJ; George N; Joshi R; Pogue J; Pais P; Yusuf S
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):244-253. PubMed ID: 26857999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of pharmacotherapy-related problems in acute coronary syndrome: Role of clinical pharmacist in cardiac rehabilitation unit.
    Casper EA; El Wakeel LM; Saleh MA; El-Hamamsy MH
    Basic Clin Pharmacol Toxicol; 2019 Jul; 125(1):44-53. PubMed ID: 30739389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific profile and referral bias of rehabilitated patients after an acute coronary syndrome.
    Cottin Y; Cambou JP; Casillas JM; Ferrières J; Cantet C; Danchin N
    J Cardiopulm Rehabil; 2004; 24(1):38-44. PubMed ID: 14758102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secondary prevention advices after cardiovascular index event: From drug prescription to risk factors control in real world practice.
    Faggiano P; Fattirolli F; Frisinghelli A; Piccioli L; Dasseni N; Silverii MV; Albricci L; D'Ambrosio G; Garrì R; Esposito L; Giallauria F
    Monaldi Arch Chest Dis; 2019 May; 89(2):. PubMed ID: 31107039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic effect of cardiac rehabilitation in the era of acute revascularisation and statin therapy: A systematic review and meta-analysis of randomized and non-randomized studies - The Cardiac Rehabilitation Outcome Study (CROS).
    Rauch B; Davos CH; Doherty P; Saure D; Metzendorf MI; Salzwedel A; Völler H; Jensen K; Schmid JP;
    Eur J Prev Cardiol; 2016 Dec; 23(18):1914-1939. PubMed ID: 27777324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secondary prevention of diabetic patients with coronary artery disease in cardiac rehabilitation: risk factors, treatment and target level attainment.
    Völler H; Reibis R; Pittrow D; Jannowitz C; Wegscheider K; Karmann B; Bestehorn K
    Curr Med Res Opin; 2009 Apr; 25(4):879-90. PubMed ID: 19254205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac rehabilitation is associated with greater improvements in psychological health following coronary artery bypass graft surgery when compared with percutaneous coronary intervention.
    Montesano M; Reed JL; Tulloch HE; Pipe AL; Terada T
    Appl Physiol Nutr Metab; 2020 Dec; 45(12):1339-1344. PubMed ID: 32544341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of LDL-Cholesterol Lowering on Cardiovascular Outcomes in Patients With Diabetes Mellitus Undergoing Coronary Revascularization.
    Farkouh ME; Godoy LC; Brooks MM; Mancini GBJ; Vlachos H; Bittner VA; Chaitman BR; Siami FS; Hartigan PM; Frye RL; Boden WE; Fuster V
    J Am Coll Cardiol; 2020 Nov; 76(19):2197-2207. PubMed ID: 33153578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypercholesterolemia diagnosis, treatment patterns and target achievement in patients with acute coronary syndromes in Germany.
    Gitt AK; Parhofer KG; Laufs U; März W; Paar WD; Bramlage P; Marx N
    Clin Res Cardiol; 2023 Feb; 112(2):299-311. PubMed ID: 36114838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan.
    Jarab AS; Alqudah SG; Mukattash TL; Shattat G; Al-Qirim T
    J Manag Care Pharm; 2012 Sep; 18(7):516-26. PubMed ID: 22971205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of a phase 2 cardiac rehabilitation program on obese and non-obese patients with stable coronary artery disease.
    El Missiri A; Abdel Halim WA; Almaweri AS; Mohamed TR
    Egypt Heart J; 2021 Jan; 73(1):4. PubMed ID: 33411160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beneficial Effects of Exercise-Based Cardiac Rehabilitation on High-Density Lipoprotein-Mediated Cholesterol Efflux Capacity in Patients with Acute Coronary Syndrome.
    Koba S; Ayaori M; Uto-Kondo H; Furuyama F; Yokota Y; Tsunoda F; Shoji M; Ikewaki K; Kobayashi Y
    J Atheroscler Thromb; 2016 Jul; 23(7):865-77. PubMed ID: 26947596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between lipoprotein(a) and revascularization after percutaneous coronary intervention in type 2 diabetes mellitus patients with acute coronary syndrome.
    Hao Y; Yang Y; Wang Y; Li J
    Curr Med Res Opin; 2022 Oct; 38(10):1663-1672. PubMed ID: 35575139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of cardiac rehabilitation in secondary prevention after coronary events.
    Peersen K; Munkhaugen J; Gullestad L; Liodden T; Moum T; Dammen T; Perk J; Otterstad JE
    Eur J Prev Cardiol; 2017 Sep; 24(13):1360-1368. PubMed ID: 28664773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.